| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/02/1990 | EP0366255A2 Method for preparing an anion exchange resin delivery system |
| 05/02/1990 | EP0366101A2 Ibuprofen taste-masking process |
| 05/02/1990 | EP0366058A2 Controlled-release delivery device, method for producing device, and method of using device |
| 05/02/1990 | EP0365997A2 A novel family of high affinity, modified antibodies for cancer treatment |
| 05/02/1990 | EP0365947A1 Novel dosage form |
| 05/02/1990 | EP0365571A1 Drug to treat the eye and suitable carrier material |
| 05/01/1990 | US4921849 Injection containing 3-benzoyloxy-1,3,5(10)-estratriene-17-[4-{p-(bis(2-chloroethyl)amino)phenyl}butanoyloxy)acetate as an active ingredient |
| 05/01/1990 | US4921690 Method of enhancing the biodistribution of antibody for localization in lesions |
| 05/01/1990 | CA2000887A1 Thromboresistant materials and methods for making same |
| 05/01/1990 | CA1268599A1 Cis-platinum complexes with a pentaerythritol derivative as the ligand, a process for their preparation and a pharmaceutical agent containing these compounds |
| 05/01/1990 | CA1268404A1 Polynucleotide assay reagent and method |
| 04/30/1990 | CA2001797A1 Topical ointment for dermatosis |
| 04/30/1990 | CA2001787A1 Modified interleukin-2 and production thereof |
| 04/27/1990 | CA2001600A1 Controlled-release delivery device, method for producing device, and method of using device |
| 04/25/1990 | EP0365480A1 Dispersible formulation |
| 04/25/1990 | EP0365439A1 Siliconate based aqueous silicone dispersion crosslinkable to an elastomer after removal of the water |
| 04/25/1990 | EP0365363A1 Parenteral formulations of 1-diphenylmethyl-4-[(2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl]piperazine |
| 04/25/1990 | EP0365119A2 Pharmaceutical composition |
| 04/25/1990 | EP0365087A1 Immunotoxins for the treatment or prophylaxis of auto-immune diseases |
| 04/25/1990 | EP0364980A2 Colony stimulating factor-gelatin conjugate |
| 04/25/1990 | EP0364944A1 Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate |
| 04/25/1990 | EP0364509A1 Cellular toxic conjugates |
| 04/25/1990 | EP0364491A1 Stabilized formulations of gamma interferons |
| 04/24/1990 | US4920145 Adducts of indomethacin, dapsone, furosemide and chlorhexidine with liquid oligomer of n-vinyl-2-pyrrolidone |
| 04/24/1990 | US4920101 For enhancing penetration of physiologically active agents through skin or other membranes |
| 04/24/1990 | US4919938 Sustained release pharmaceutical compositions in oral dosage form |
| 04/24/1990 | US4919937 Percutaneous administration of tamoxifen |
| 04/24/1990 | US4919928 Conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, their use as immunotoxin potentiators and the intermediate activated ionophores |
| 04/24/1990 | US4919927 Using ammonium chloride |
| 04/24/1990 | CA2001373A1 Methods and compositions for diagnosing, monitoring and treating the early stage of osteoarthritis |
| 04/24/1990 | CA1268119A1 Parenteral phenytoin preparations |
| 04/21/1990 | CA2001170A1 Parenteral formulations of 1-diphenylmethyl-4-¬(2-(4-methylphenyl)-5 methyl-1h-imidazol-4-yl) methyl| piperazine |
| 04/21/1990 | CA2000999A1 Immunotoxins for the treatment of prophylaxis of auto-immune diseases |
| 04/19/1990 | WO1990003810A1 Delayed release compositions for wound healing |
| 04/19/1990 | WO1990003801A1 Vasopermeability-enhancing conjugates |
| 04/19/1990 | WO1990003798A2 Targetting agents |
| 04/19/1990 | WO1990003797A1 Stabilized composition based on growth factors of the family fgf and on dextrane sulfate, and its applications |
| 04/19/1990 | WO1990003796A1 Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same |
| 04/19/1990 | WO1990003795A1 Method of making liposomes with improved stability during drying |
| 04/19/1990 | WO1990003784A1 Cyclodextrin-peptide complexes |
| 04/19/1990 | WO1990003783A1 Polylactide compositions |
| 04/19/1990 | WO1990003781A1 Pharmaceutical composition containing a hydrophilic active compound treated by an organic acid and encapsulated in a liposome |
| 04/19/1990 | WO1990003776A1 Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith |
| 04/19/1990 | WO1990003768A1 Biodegradable in-situ forming implants |
| 04/18/1990 | EP0364375A1 Aqueous silicone dispersion containing an alkenyl silane crosslinker and curing into an elastomer by removal of water |
| 04/18/1990 | EP0364235A1 Physiologically active peptide composition for nasal administration |
| 04/18/1990 | EP0364211A1 A percutaneous pharmaceutical preparation |
| 04/18/1990 | EP0364157A2 Hydrogenated deodorized polyisobutylenes for cosmetics |
| 04/18/1990 | EP0363876A1 Pharmaceutical compositions comprising calcitonin for intra-nasal administration and a spray unit for the administration of the same |
| 04/18/1990 | EP0363835A1 Use of zinc or iron hydroxide in the adjuvation of antigen solutions, and antigen solutions adjuvated in this manner |
| 04/18/1990 | EP0363712A2 Hybrid monoclonal antibodies, their production and use |
| 04/18/1990 | EP0363502A1 Liquid formulation containing bismuth, process to prepare it and use thereof |
| 04/18/1990 | CA2000989A1 Conjugates of soluble t4 proteins and toxins and methods for treating or preventing aids, arc and hiv infection |
| 04/17/1990 | US4918177 Sialic acid derivatives having active carbonyl group |
| 04/17/1990 | US4918165 Anticollagen antibody and cytotoxin conjugate |
| 04/17/1990 | US4918108 Method of improving the absorption of injected antibacterial substances |
| 04/17/1990 | US4918103 Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
| 04/17/1990 | US4917900 Controlled release formulations containing zidovudine |
| 04/17/1990 | US4917896 Piperazine, morpholine or thiomorpholine derivative |
| 04/17/1990 | US4917892 Semipermeability anisotropic reaction product of polyfunctional lewis acid or salt and lewis base or salt |
| 04/17/1990 | US4917891 Composition having evaporative oil-like material |
| 04/17/1990 | US4917888 Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation |
| 04/17/1990 | US4917886 Novel topically administrable pharmaceutical compositions |
| 04/17/1990 | US4917685 Porous membrane confining active materials and stabilizers |
| 04/17/1990 | CA2000837A1 Gel bases for pharmaceutical compositions |
| 04/17/1990 | CA1267848A1 Aqueous composition containing sodium cromoglycate |
| 04/17/1990 | CA1267844A1 Non-aqueous ivermectin formulation with improved antiparasitic activity |
| 04/17/1990 | CA1267843A1 Process for preparing sucrose encrusted methylcellulose particles for use in bulk laxative compositions |
| 04/14/1990 | CA2000697A1 Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith |
| 04/11/1990 | EP0363275A1 Low molecular weight vectors specific for sugar receptors, their conjugates and processes for their preparation |
| 04/11/1990 | EP0362508A2 Colour stabilization of antimicrobial preparations |
| 04/11/1990 | EP0362339A1 Process for immobilizing or depositing molecules or substances on a support. |
| 04/11/1990 | EP0362321A1 Ophthalmic suspensions. |
| 04/11/1990 | CN1041103A Pharmaceutical compositions in form of beadlets and method |
| 04/10/1990 | US4916213 Treatment of bone, colon and ovarian cancers; kits |
| 04/10/1990 | US4916161 Taste-masking pharmaceutical agents |
| 04/10/1990 | US4916138 Solid dispersion composition of FR-900506 substance |
| 04/10/1990 | US4915945 Absorption of concomitant protein onto hydrophobic carrier |
| 04/10/1990 | US4915934 Foamable biocide composition |
| 04/10/1990 | EP0321499A4 Covalently bonded active agents with carbonium ion base groups. |
| 04/10/1990 | CA1267605A1 Pharmaceutical composition containing phenindamine |
| 04/10/1990 | CA1267602A1 Composition containing tissue plasminogen activator |
| 04/10/1990 | CA1267582A1 Oil-in-water emulsions with increased viscosity under shear stress |
| 04/07/1990 | CA2000337A1 Chemical compounds |
| 04/07/1990 | CA2000254A1 Stabilized compound of fgf-family growth factors and dextran sulfate and it a applications |
| 04/05/1990 | WO1990003401A1 Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages |
| 04/05/1990 | WO1990003399A1 Amino acid transport proteins, amino acid analogues, assay apparatus, uses thereof for treatment and diagnosis of cancer |
| 04/05/1990 | WO1990003188A1 Cleavable linkers for the reduction of non-target organ retention of immunoconjugates |
| 04/05/1990 | WO1990003185A1 Combination enzyme immunotherapeutics |
| 04/05/1990 | WO1990003174A1 Compositions for the treatment of leishmaniasis |
| 04/05/1990 | WO1990003173A1 Stable aqueous preparation of active vitamin d¿3? |
| 04/05/1990 | WO1990003167A1 Compositions and methods for administering therapeutically active compounds |
| 04/05/1990 | WO1990003166A2 Method and composition for the treatment of burns |
| 04/05/1990 | WO1990003165A1 Directly compressible sustained release excipient |
| 04/05/1990 | WO1990003163A1 Composition and method for enhancing permeability of topical drugs |
| 04/05/1990 | CA2000219A1 Method of making liposomes with improved stability during drying |
| 04/05/1990 | CA2000157A1 Low molecular weight syntheticcarners specific to sugar receptors, conjugates containing such carriers and preparation processes |
| 04/04/1990 | EP0361908A2 Combination enzyme immunotherapeutics |
| 04/04/1990 | EP0361722A2 Antibacterial adhesive composition |
| 04/04/1990 | EP0361680A2 Morphine-containing composition |